Significant rise in incidences of colorectal cancer and benign strictures in the U.S are the major factors driving the U.S. colonic stents market. In addition, increase in demand for minimally invasive procedures and technological advancements regarding the development of more compatible metallic stents further propels the market growth of colonic stents in the near future. However, complications and high costs associated with colonic stents is anticipated to hamper the growth of the colonic stents market in the U.S. Moreover, colonic stenting improves the primary anastomosis rate with a low stoma creation in comparison with emergency surgery. Improved colonic stent such as self-expandable metallic stents (SEMS) is used for the bridge to surgery and it also able to cure patients with the palliative intent with advanced neoplastic disease, to avoid stoma and health care costs related to stoma. This provides a lucrative opportunity for the growth of the U.S. colonic stents market.
The report covers the U.S. colonic stents market forecast and analysis based on three categories that include product type, indication, and end user. Based on product type, the market is categorized into nitinol self-expandable metal stents, and elgiloy self-expandable metal stents. On the basis of indication, it is categorized into colorectal cancer, colonic benign strictures and others. By end user, the market is bifurcated into hospitals and specialty clinics.
KEY BENEFITS FOR STAKEHOLDERS
- This report entails a detailed quantitative analysis along with the current U.S. colonic stents market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
- The market size and estimations are based on a comprehensive analysis of key developments in the industry.
- A qualitative analysis based on innovative products facilitates strategic business planning.
- The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
By Product Type
Self-Expandable Metal Stents
o Nitinol Stent
- Colorectal Cancer/Bridge to Surgery
- Benign Colonic Strictures
- Other Indications
- Specialty Clinics
- Boston Scientific Corporation
- Cook Medical Inc
- Cook Medical Inc
- Olympus Corporation
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market share analysis, 2018
3.5. Market dynamics
184.108.40.206. High incidence of colorectal cancer in the U.S.
220.127.116.11. Significant agreements and collaborations in the colonic stent industry
18.104.22.168. Product recalls associated with colonic stents
22.214.171.124. Development of innovative smartphone applications
3.6. Pricing Analysis, 2018-2026
CHAPTER 4: U.S. COLONIC STENTS MARKET, BY PRODUCT TYPE
4.1.1. Self-Expandable Metal Stents (SEMSs)
126.96.36.199. Market size and forecast
188.8.131.52. Nitinol Stent
184.108.40.206.1. Market size and forecast
220.127.116.11. Elgiloy stent
18.104.22.168.1. Market size and forecast
CHAPTER 5: U.S. COLONIC STENTS MARKET, BY INDICATION
5.1.1. Market size and forecast
5.2. Colorectal Cancer/Bridge to Surgery
5.2.1. Market size and forecast
5.3. Colonic benign strictures
5.3.1. Market size and forecast
5.4. Other Indications
5.4.1. Market size and forecast
CHAPTER 6: U.S. COLONIC STENTS MARKET, BY END USER
6.1.1. Market size and forecast
6.2.1. Market size and forecast
6.3. Specialty Clinics
6.3.1. Market size and forecast
CHAPTER 7: COMPANY PROFILES
7.1. BOSTON SCIENTIFIC CORPORATION
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product Portfolio
7.1.5. Business performance
7.2. COOK MEDICAL INC.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.3. ELLA - CS, s.r.o. (ELLA-CS)
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.5. M.I. TECH
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Key strategic moves and developments
7.6. Olympus Corporation
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
Colonic stent is widely use for the treatment of the colorectal cancer. It helps to keep the segment of the large bowel open, when it becomes blocked by a stricture or a tumor. Stents can be used when there is either a partial or complete blockage in the bowel to reduce the pressure in the bowel and relieve the obstruction. The major factors which drive the growth of this market include high prevalence of colorectal cancer in the U.S., and surge in demand for minimally invasive procedures However, high costs associated with colonic stents are anticipated to restrain the market growth during the forecast period.
The major factors that drive the market growth include significant rise in incidences of colorectal cancer in the U.S., and technological advancements associated with colonic stents such as usage of self-expanding alloys in the manufacturing of stents. However, complications and high costs associated with colonic stents is anticipated to hamper the growth of the colonic stents market in the U.S. Moreover, colonic stenting improves the primary anastomosis rate with a low stoma creation in comparison with emergency surgery. Improved colonic stent such as self-expandable metallic stents (SEMS) is used for the bridge to surgery and it also able to cure patients with the palliative intent with advanced neoplastic disease, to avoid stoma and health care costs related to stoma. This provides a lucrative opportunity for the growth of the U.S. colonic stents market.
The colonic stents market is segmented based on product type, indication, and end user. Based on product type, the self-expandable metal stents segment held the largest share in 2018, due to high usage of self-expandable metal stents for acute malignant large bowel obstruction and for palliative patients.
By indication, the market is segmented into colorectal cancer/bridge to surgery, benign colonic strictures, and other indications. Among these, the colorectal cancer segment garnered the largest share in 2018 as colorectal cancer is the third most common cancer diagnosed in both men and women in the U.S. and is expected to lead the market during the analysis period.
By end user, the market is divided into hospitals and specialty clinics. Amongst these, hospital segment gathered the major U.S. colonic stents market share in 2018, due to easy availability of these equipment and all other facilities required for the stenting procedure are in the hospitals.
Key Findings of the U.S. Colonic Stents Market:
Based on type, the nitinol colonic stent held the majority of market share in 2018 and is anticipated to continue its dominance during the forecast period.
The colorectal cancer segment based on indication accounted for the largest market share in 2018 and is also estimated to grow at the highest CAGR of 4.6%.
By end user, hospital segment held the highest market share and expected to lead the market during the analysis period.
The U.S. colonic stents market is highly competitive and the prominent players in the market have adopted various strategies for garnering maximum market share. These include expansion of their geographical presence through collaborations and focus on R&D activities for the development of metal stents.
Major players operating in the market include Boston Scientific Corporation, Cook Medical Inc., Ella-CS, Taewoong, MI-TECH and Olympus Corporation.
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.